Laboratory Corporation Of America Holdings (LH): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Laboratory Corporation of America Holdings ( LH) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.3%. By the end of trading, Laboratory Corporation of America Holdings rose $1.02 (1.1%) to $91 on average volume. Throughout the day, 1.1 million shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 821,300 shares. The stock ranged in a price between $89.55-$91.04 after having opened the day at $89.85 as compared to the previous trading day's close of $89.98. Other companies within the Health Services industry that increased today were: Biolase ( BIOL), up 19.4%, Sunshine Heart ( SSH), up 14.1%, ImmunoCellular Therapeutics ( IMUC), up 13.1%, and Kips Bay Medical ( KIPS), up 7.2%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of diseases. Laboratory Corporation of America Holdings has a market cap of $8.5 billion and is part of the health care sector. The company has a P/E ratio of 14.8, below the S&P 500 P/E ratio of 17.7. Shares are up 3.7% year to date as of the close of trading on Tuesday. Currently there are two analysts that rate Laboratory Corporation of America Holdings a buy, two analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, notable return on equity, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

INC Research Holdings Seen as Likely LabCorp. Takeover Target

5 Big Stocks to Buy for Big Gains

Laboratory Corp Of America Holdings (LH) Hits New Lifetime High Today